
Several US-based Environmental Science Databases To Be Taken Down
decommissioned starting next month.
Earlier this month, NOAA announced changes affecting data sources related to earthquakes and marine, coastal, and estuary science.
This comes amid wider concerns about publicly available scientific data in the US being taken down and measures to cut research funding, including at NOAA, by the current government.
The SMC asked experts to comment on what impact the database closures will have in Aotearoa.
Professor Craig Stevens, Department of Physics, University of Auckland, comments:
Note: Professor Stevens' comments on US science funding cuts in February are available here.
'The global climate science community over the last decade or so has been working towards FAIR (Findable, Accessible, Interoperable, and Reusable) data principles and making data as readily findable as possible. I would say most of these databases look reasonably low traffic and so NOAA, faced with dramatic cuts, is doing what it can to maintain critical functions. Also there looks to be a trail to archives with the data saved or the function taken on by some other instrument. But you never know of course, there will always be someone out there who has made something of the data and systems. And as we are seeing with various climate data, just because something is old and obscure doesn't mean it isn't valuable. These closures make this findability harder, and moreover, it is likely the tip of the iceberg in terms of coming impacts of reduced funding.'
Conflict of interest statement: Prof Stevens regularly collaborates with US government-funded colleagues. Prof Stevens is on the council of the NZ Association of Scientists.
Dr James Renwick, Professor of Physical Geography, Victoria University of Wellington, comments:
'The loss of environmental services and products eat away at our knowledge of the world around us. The recent news of cuts to NOAA and the NWS have been hugely concerning for weather, climate and climate sciences worldwide. However, this announcement of changes at NOAA do not seem so bad from my point of view. Many products and services will be replaced by newer or slightly different products, with not many discontinued altogether – at this stage at least. Set in the context of the major cuts to staffing and funding going on in the US to agencies like NOAA, I am concerned about what will happen next.'
Conflict of interest statement: 'I have many colleagues and friends at NOAA, NWS and other US agencies, and I have worked collaboratively with them on international projects and conferences. I receive no funding directly from the US.'
Our colleagues at the Taiwan SMC have also gathered expert comments in response to the closures and their impact on Taiwan. Below are machine-generated English translations of summaries of three expert comments. The translations have been checked by the authors for accuracy.
Huang, Wan-Ru, Prof. & Chair of the Department of Earth Sciences, National Taiwan Normal University:
Wan-Ru Huang pointed out that NOAA data is a core resource when doing analysis, simulation, teaching and even course training. Not only does it have complete data, long time series, and a consistent format, it also has processed climate averages and anomalies, which saves a lot of time and can be used directly for diagnosis or incorporated into a statistical framework. For researchers, it is a 'directly usable and reliable' source of information.
Wan-Ru Huang believes that the impact of closing the database will be direct and specific. Because the local data that researchers have is actually limited in spatial and temporal coverage when it comes to regional scales or when it comes to linking with global climate variability. Many research processes are built on the basis of NOAA data. If they are suddenly interrupted now, in addition to rebuilding the data process, the entire research design will also be affected, and even the direction of students' thesis may be disrupted.
Wan-Ru Huang explained that what is more worrying is that many new researchers or students actually rely on open data such as NOAA to learn analysis and do research. If even getting started becomes difficult, the talent training and research energy of the entire academic community will be affected in the long run.
Min-Hui Lo, Professor of Atmospheric Sciences, National Taiwan University:
Professor Min-Hui Lo indicated that NOAA's observational and simulation data allow scientists to track short-term weather events such as heatwaves and rainstorms, analyze long-term climate trends, and investigate issues related to global warming and its impacts. This information is essential for understanding the functioning of the Earth system, building numerical simulation models, and developing effective strategies to address climate change.
Professor Lo emphasized that NOAA's databases have a profound impact on scientific research, which are widely used in global Earth system studies and climate model development. Many international research efforts rely heavily on the availability of these high-quality datasets for robust analysis. He further noted that when long-term observation data are discontinued or no longer updated, it becomes increasingly difficult to assess climate change trends and impacts accurately. Moreover, future scientists may find it challenging to trace back and explain events without continuous, high-quality data records.
Chen, Min-Te, Distinguished Professor and Director of the Institute of Earth Sciences, National Taiwan Ocean University:
Min-Te Chen expressed deep concern about the news that some databases will be closed soon. Min-Te Chen believes that this move will not only have an impact on the global ocean and earth science community, but will also have a more substantial impact on Taiwan's rapidly developing offshore engineering and disaster warning systems.
Min-Te Chen gave examples to explain that NOAA's seabed sediment thickness, crust age and volcanic distribution data have always been an indispensable reference for the early stages of submarine cable planning. Its closure will require relevant units to incur higher costs to build their own data, or they may risk carrying out projects based on incomplete information.
Min-Te Chen believes that the most regrettable thing is that NOAA's volcanic eruption records and seismic reflection data are among the few public, high-quality and long-term data sources in the world. Its closure may lead to a reduction in the accuracy of early warning simulations. For countries like Taiwan that are vulnerable to undersea earthquakes and tsunamis, the risks should not be underestimated.
Min-Te Chen believes that our government agencies and academic institutions should back up necessary data as quickly as possible and evaluate the possibility of establishing alternative databases or cooperating with international organizations. At the same time, we hope that NOAA will review the closure plan and provide relocation or extended access methods to avoid long-term adverse effects on global earth science research and marine engineering.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Scoop
04-06-2025
- Scoop
Dengue In The Pacific Region – Expert Q&A
Press Release – Science Media Centre The SMC asked experts about the current situation in the Pacific. The Cook Islands declared a dengue outbreak in Rarotonga last week. Other Pacific nations including Sāmoa, Tonga, and Fiji are also experiencing outbreaks. The SMC asked experts about the current situation in the Pacific. Dr Gregor Devine, Senior Director, Field Entomology at the World Mosquito Program, comments: What is the immediate threat posed by dengue in the wider Pacific region, and how is this changing? 'Dengue fever is the world's most prevalent disease spread by mosquitoes. Cases are increasing across the Western Pacific (e.g., Pacific Island Countries and Territories, Laos, Cambodia, Vietnam) and South East Asia (e.g., Bangladesh, Indonesia, Thailand, and Timor-Leste). All of these countries experienced significant dengue outbreaks in 2024 and 2025, and the general trend in cases globally is relentlessly upwards. 'These increases are fuelled by 1) climate change (increased temperatures encourage mosquito proliferation and shorten the time needed for viruses to replicate in their mosquito hosts), 2) increasing globalisation (and the increased movement of humans carrying the virus), 3) immunological naïveté, where human populations are being exposed to new dengue serotypes, and 4) the limited impact of existing control measures. 'According to the Pacific Syndromic Surveillance System, as of May 27th 2025, dengue cases are increasing or peaking in Fiji, Samoa, Tonga, Kiribati, and Cook Islands. There have been deaths reported from Fiji, Tonga and Samoa.' What hopes are currently on the horizon for new technologies or programmes to combat the disease? 'Current responses to dengue outbreaks largely involve the application of insecticides and the implementation of environmental 'clean-up' campaigns, but these have limited impacts. Moreover, resistance to insecticides is increasingly documented in the Pacific, and this further reduces the impact of conventional vector control. 'A safe, effective and sustainable solution exists. The Wolbachia method, developed by the non-profit World Mosquito Program, involves releasing mosquitoes infected with a bacteria that reduces their ability to transmit dengue. It has been proven to have a tremendous impact on dengue transmission around the world. Wolbachia releases have been piloted in Fiji, Vanuatu, Kiribati, and New Caledonia. Following six years of Wolbachia mosquito releases in New Caledonia, the project has been hailed a monumental success, and the French territory hasn't had a dengue epidemic since 2019. This year, releases will continue in Kiribati, and be adopted in Timor-Leste.' What is your biggest concern and/or is there anything you wish people understood better about the situation? 'The upward trend in dengue case numbers regionally will inevitably stress public health systems and impact family well-being (through both the health and economic costs of hospitalisation and the lost earnings of the sick). Sustainable ways to combat dengue, such as the Wolbachia method, are desperately needed. Vaccines are still years away from being universally affordable and applicable.' Conflict of interest statement: Greg Devine is the Senior Director of Field Entomology for the World Mosquito Program Dr Joan Ingram, Medical Advisor, Immunisation Advisory Centre, comments: What is the immediate threat posed by dengue in the Pacific region, and how is this changing? 'Dengue outbreaks are currently affecting Kiribati, Samoa, Fiji, Tonga and French Polynesia with the most cases being reported from Fiji, according to The Pacific Community (SPC). Case numbers are increasing in all of those areas, apart from in French Polynesia. There are four dengue serotypes – and both serotype 1 and serotype 2 are currently circulating. 'The Pacific Islands are vulnerable to dengue outbreaks as they have high levels of mosquitoes and dengue viruses can be introduced by infected people. 'Between 2012 and 2021, there were 69 outbreaks of dengue fever among the Pacific Islands. However, they are not unique in having dengue fever – dengue is common in many other regions including the Americas, Africa, the Middle East and Asia. 'Globally, dengue cases were at a very high level in 2024, particularly in South America. Cases increased almost 30-fold there between 2000 and 2024. Urbanisation, globalisation and climate change have contributed to this increase.' What is your biggest concern and is there anything you wish people understood better about the situation? 'Dengue is often a leading cause of fever in risk countries. Estimates are that around 6 in 1000 travellers spending a month in a risk area become unwell with dengue, with up to 30% of them being hospitalised. 'Dengue is spread by common biting mosquitoes (various Aedes species), which thrive where humans live. The main way to avoid dengue is mosquito bite avoidance. Aedes mosquitoes (unlike the malaria-transmitting Anopheles) are daytime feeders, with two peak times of biting activity in the day – 2 to 3 hours after dawn, and mid-to-late afternoon. However, they may feed all day indoors or on overcast days. 'People should regularly apply effective repellent as well as using light-coloured clothing to cover up. In addition, they should take steps to reduce mosquitoes indoors (such as screens on windows and doors), and in the environment by emptying any water-holding containers.' What hopes are currently on the horizon for new technologies or programmes to combat the disease? 'Qdenga, a dengue vaccine, is available in 30 countries overseas but not in New Zealand. It protects against dengue serotype 1 and 2 very well, especially in people who have had previous dengue. Protection against serotypes 3 and 4 is still being evaluated. 'An earlier dengue vaccine increased the risk of severe dengue in people who had not had dengue previously. It does not seem as though Qdenga does that, but it is still being monitored and most authorities prefer to administer it to people with past dengue infection although the guidelines differ. 'A new hope for the future is the use of Wolbachia-infected Aedes aegypti. Wolbachia infection blocks the transmission of the dengue virus from mosquitoes. Trials are ongoing with promising results.' No conflicts of interest. Dr Berlin Kafoa, Director, Public Health Division at The Pacific Community (SPC), comments: What is the immediate threat posed by dengue in the Pacific region, and how is this changing? ' 1. Increasing morbidity due to escalating dengue outbreaks reported across the Pacific region with circulation of multiple serotypes. 'Dengue is actively circulating in at least six Pacific Island Countries and Territories (PICTs), including Fiji (>8,000 cases, 4 deaths), Tonga (793 cases, 3 deaths), French Polynesia (>2,000 cases), Samoa (110 cases, 1 death), Cook Islands, and Kiribati. Multiple serotypes (DENV-1, DENV-2, DENV-3) are co-circulating, increasing the risk of severe dengue due to secondary infections in populations with partial immunity. ' 2. Changing epidemiology and vulnerable populations 'There is a growing incidence of severe dengue amongst children and youth with no prior dengue exposure. There are older adults coming from areas historically free of dengue. This suggests immunity gaps, but the lack of updated seroprevalence data limits precise risk profiling. ' 3. Climate and mobility as amplifiers 'Climate change and variability (e.g., rainfall, temperature) is expanding mosquito habitats and altering transmission regional and international travel and trade from endemic areas (e.g., Southeast Asia, South America) raises the risk of virus introduction.' What hopes are currently on the horizon for new technologies or programmes to combat the disease? ' 1. A need for collaboration across sectors, agencies, and countries. 'Through the Pacific Public Health Surveillance Network (PPHSN), we are working with WHO and allied members to support countries with preparedness, detection and response to dengue and other arboviral diseases. This includes: Rapid risk assessments and technical guidance Laboratory supplies and testing algorithms and Strengthening PCR testing capabilities in countries. Subtyping and WGS/Whole-Genome Sequencing via reference labs (e.g., VIDRL in Australia). Dissemination of risk communication messages through multiple channels and sharing of best practices in risk communication and community engagement ' 2. A need for predictive analytics and early warning 'We are exploring predictive algorithms that integrate climate data (e.g., rainfall, temperature), flight and mobility data, and historical outbreak and seroprevalence data. These tools aim to forecast outbreak risks and optimize vector control timing.' ' 3. Vector control capacity building to promote a One Health approach. 'The Pacific Vector Network (PVN) launched in 2023, a service arm of PPHSN, supports a coordinated response to control of vector-borne disease in the region; practical entomology training for PICTs; mosquito surveys, mapping, and surveillance; and provision of vector control equipment and insecticides.' ' 4. New tools being tested 'Other new tools being tested in the region include pilot testing of new technologies such as Sterile Insect Technique (SIT) in French Polynesia, and trials of Wolbachia introduction in Fiji, Vanuatu, New Caledonia, and Kiribati. For possible consideration, there is the introduction of dengue vaccines-contingent on availability of sero-prevalence data.' What is your biggest concern and/or is there anything you wish people understood better? 'The real risk of severe dengue is rising. Severe cases and fatalities are being reported, especially among youth. Dengue should not be dismissed as a mild illness, it can be life-threatening. 'There are gaps in immunity and surveillance. Many populations remain immunologically naive due to limited past exposure. Inadequate seroprevalence data and diagnostic capacity hinder targeted responses. 'There are changes in vector behaviours with possible increase in behaviours resistance to insecticides. 'Dengue is not the only arboviral threat which further complicates surveillance, diagnosis, and response efforts. Other threats include: Zika: Imported cases have been reported in the Pacific Rim (e.g., New Zealand from Fiji). Chikungunya: A major outbreak in La Réunion (339,000+ cases) and an imported case in Wallis and Futuna. Yellow fever: While not yet reported in the Pacific, the presence of Aedes vectors makes introduction a real risk 'There is a need to support the Pacific to acquire new technology for genomic surveillance. Genetic sequencing of dengue strains is essential to track virus movement and mutations across the region, but capacity remains limited. 'Dengue is no longer a seasonal or isolated threat in the Pacific; it is a regional health emergency shaped by climate, mobility, and historical vulnerabilities. Through a One Health multisector, multiagency and multi-country collaborative efforts with WHO, PIHOA and PPHSN partners, we are responding and building the tools and intelligence to predict, prepare and hopefully prevent the next wave.'


Scoop
04-06-2025
- Scoop
Dengue In The Pacific Region – Expert Q&A
Press Release – Science Media Centre The SMC asked experts about the current situation in the Pacific. The Cook Islands declared a dengue outbreak in Rarotonga last week. Other Pacific nations including Sāmoa, Tonga, and Fiji are also experiencing outbreaks. The SMC asked experts about the current situation in the Pacific. Dr Gregor Devine, Senior Director, Field Entomology at the World Mosquito Program, comments: What is the immediate threat posed by dengue in the wider Pacific region, and how is this changing? 'Dengue fever is the world's most prevalent disease spread by mosquitoes. Cases are increasing across the Western Pacific (e.g., Pacific Island Countries and Territories, Laos, Cambodia, Vietnam) and South East Asia (e.g., Bangladesh, Indonesia, Thailand, and Timor-Leste). All of these countries experienced significant dengue outbreaks in 2024 and 2025, and the general trend in cases globally is relentlessly upwards. 'These increases are fuelled by 1) climate change (increased temperatures encourage mosquito proliferation and shorten the time needed for viruses to replicate in their mosquito hosts), 2) increasing globalisation (and the increased movement of humans carrying the virus), 3) immunological naïveté, where human populations are being exposed to new dengue serotypes, and 4) the limited impact of existing control measures. 'According to the Pacific Syndromic Surveillance System, as of May 27th 2025, dengue cases are increasing or peaking in Fiji, Samoa, Tonga, Kiribati, and Cook Islands. There have been deaths reported from Fiji, Tonga and Samoa.' What hopes are currently on the horizon for new technologies or programmes to combat the disease? 'Current responses to dengue outbreaks largely involve the application of insecticides and the implementation of environmental 'clean-up' campaigns, but these have limited impacts. Moreover, resistance to insecticides is increasingly documented in the Pacific, and this further reduces the impact of conventional vector control. 'A safe, effective and sustainable solution exists. The Wolbachia method, developed by the non-profit World Mosquito Program, involves releasing mosquitoes infected with a bacteria that reduces their ability to transmit dengue. It has been proven to have a tremendous impact on dengue transmission around the world. Wolbachia releases have been piloted in Fiji, Vanuatu, Kiribati, and New Caledonia. Following six years of Wolbachia mosquito releases in New Caledonia, the project has been hailed a monumental success, and the French territory hasn't had a dengue epidemic since 2019. This year, releases will continue in Kiribati, and be adopted in Timor-Leste.' What is your biggest concern and/or is there anything you wish people understood better about the situation? 'The upward trend in dengue case numbers regionally will inevitably stress public health systems and impact family well-being (through both the health and economic costs of hospitalisation and the lost earnings of the sick). Sustainable ways to combat dengue, such as the Wolbachia method, are desperately needed. Vaccines are still years away from being universally affordable and applicable.' Conflict of interest statement: Greg Devine is the Senior Director of Field Entomology for the World Mosquito Program Dr Joan Ingram, Medical Advisor, Immunisation Advisory Centre, comments: What is the immediate threat posed by dengue in the Pacific region, and how is this changing? 'Dengue outbreaks are currently affecting Kiribati, Samoa, Fiji, Tonga and French Polynesia with the most cases being reported from Fiji, according to The Pacific Community (SPC). Case numbers are increasing in all of those areas, apart from in French Polynesia. There are four dengue serotypes – and both serotype 1 and serotype 2 are currently circulating. 'The Pacific Islands are vulnerable to dengue outbreaks as they have high levels of mosquitoes and dengue viruses can be introduced by infected people. 'Between 2012 and 2021, there were 69 outbreaks of dengue fever among the Pacific Islands. However, they are not unique in having dengue fever – dengue is common in many other regions including the Americas, Africa, the Middle East and Asia. 'Globally, dengue cases were at a very high level in 2024, particularly in South America. Cases increased almost 30-fold there between 2000 and 2024. Urbanisation, globalisation and climate change have contributed to this increase.' What is your biggest concern and is there anything you wish people understood better about the situation? 'Dengue is often a leading cause of fever in risk countries. Estimates are that around 6 in 1000 travellers spending a month in a risk area become unwell with dengue, with up to 30% of them being hospitalised. 'Dengue is spread by common biting mosquitoes (various Aedes species), which thrive where humans live. The main way to avoid dengue is mosquito bite avoidance. Aedes mosquitoes (unlike the malaria-transmitting Anopheles) are daytime feeders, with two peak times of biting activity in the day – 2 to 3 hours after dawn, and mid-to-late afternoon. However, they may feed all day indoors or on overcast days. 'People should regularly apply effective repellent as well as using light-coloured clothing to cover up. In addition, they should take steps to reduce mosquitoes indoors (such as screens on windows and doors), and in the environment by emptying any water-holding containers.' What hopes are currently on the horizon for new technologies or programmes to combat the disease? 'Qdenga, a dengue vaccine, is available in 30 countries overseas but not in New Zealand. It protects against dengue serotype 1 and 2 very well, especially in people who have had previous dengue. Protection against serotypes 3 and 4 is still being evaluated. 'An earlier dengue vaccine increased the risk of severe dengue in people who had not had dengue previously. It does not seem as though Qdenga does that, but it is still being monitored and most authorities prefer to administer it to people with past dengue infection although the guidelines differ. 'A new hope for the future is the use of Wolbachia-infected Aedes aegypti. Wolbachia infection blocks the transmission of the dengue virus from mosquitoes. Trials are ongoing with promising results.' No conflicts of interest. Dr Berlin Kafoa, Director, Public Health Division at The Pacific Community (SPC), comments: What is the immediate threat posed by dengue in the Pacific region, and how is this changing? ' 1. Increasing morbidity due to escalating dengue outbreaks reported across the Pacific region with circulation of multiple serotypes. 'Dengue is actively circulating in at least six Pacific Island Countries and Territories (PICTs), including Fiji (>8,000 cases, 4 deaths), Tonga (793 cases, 3 deaths), French Polynesia (>2,000 cases), Samoa (110 cases, 1 death), Cook Islands, and Kiribati. Multiple serotypes (DENV-1, DENV-2, DENV-3) are co-circulating, increasing the risk of severe dengue due to secondary infections in populations with partial immunity. ' 2. Changing epidemiology and vulnerable populations 'There is a growing incidence of severe dengue amongst children and youth with no prior dengue exposure. There are older adults coming from areas historically free of dengue. This suggests immunity gaps, but the lack of updated seroprevalence data limits precise risk profiling. ' 3. Climate and mobility as amplifiers 'Climate change and variability (e.g., rainfall, temperature) is expanding mosquito habitats and altering transmission regional and international travel and trade from endemic areas (e.g., Southeast Asia, South America) raises the risk of virus introduction.' What hopes are currently on the horizon for new technologies or programmes to combat the disease? ' 1. A need for collaboration across sectors, agencies, and countries. 'Through the Pacific Public Health Surveillance Network (PPHSN), we are working with WHO and allied members to support countries with preparedness, detection and response to dengue and other arboviral diseases. This includes: Rapid risk assessments and technical guidance Laboratory supplies and testing algorithms and Strengthening PCR testing capabilities in countries. Subtyping and WGS/Whole-Genome Sequencing via reference labs (e.g., VIDRL in Australia). Dissemination of risk communication messages through multiple channels and sharing of best practices in risk communication and community engagement ' 2. A need for predictive analytics and early warning 'We are exploring predictive algorithms that integrate climate data (e.g., rainfall, temperature), flight and mobility data, and historical outbreak and seroprevalence data. These tools aim to forecast outbreak risks and optimize vector control timing.' ' 3. Vector control capacity building to promote a One Health approach. 'The Pacific Vector Network (PVN) launched in 2023, a service arm of PPHSN, supports a coordinated response to control of vector-borne disease in the region; practical entomology training for PICTs; mosquito surveys, mapping, and surveillance; and provision of vector control equipment and insecticides.' ' 4. New tools being tested 'Other new tools being tested in the region include pilot testing of new technologies such as Sterile Insect Technique (SIT) in French Polynesia, and trials of Wolbachia introduction in Fiji, Vanuatu, New Caledonia, and Kiribati. For possible consideration, there is the introduction of dengue vaccines-contingent on availability of sero-prevalence data.' What is your biggest concern and/or is there anything you wish people understood better? 'The real risk of severe dengue is rising. Severe cases and fatalities are being reported, especially among youth. Dengue should not be dismissed as a mild illness, it can be life-threatening. 'There are gaps in immunity and surveillance. Many populations remain immunologically naive due to limited past exposure. Inadequate seroprevalence data and diagnostic capacity hinder targeted responses. 'There are changes in vector behaviours with possible increase in behaviours resistance to insecticides. 'Dengue is not the only arboviral threat which further complicates surveillance, diagnosis, and response efforts. Other threats include: Zika: Imported cases have been reported in the Pacific Rim (e.g., New Zealand from Fiji). Chikungunya: A major outbreak in La Réunion (339,000+ cases) and an imported case in Wallis and Futuna. Yellow fever: While not yet reported in the Pacific, the presence of Aedes vectors makes introduction a real risk 'There is a need to support the Pacific to acquire new technology for genomic surveillance. Genetic sequencing of dengue strains is essential to track virus movement and mutations across the region, but capacity remains limited. 'Dengue is no longer a seasonal or isolated threat in the Pacific; it is a regional health emergency shaped by climate, mobility, and historical vulnerabilities. Through a One Health multisector, multiagency and multi-country collaborative efforts with WHO, PIHOA and PPHSN partners, we are responding and building the tools and intelligence to predict, prepare and hopefully prevent the next wave.'


Scoop
04-06-2025
- Scoop
Dengue In The Pacific Region – Expert Q&A
The Cook Islands declared a dengue outbreak in Rarotonga last week. Other Pacific nations including Sāmoa, Tonga, and Fiji are also experiencing outbreaks. The SMC asked experts about the current situation in the Pacific. Dr Gregor Devine, Senior Director, Field Entomology at the World Mosquito Program, comments: What is the immediate threat posed by dengue in the wider Pacific region, and how is this changing? 'Dengue fever is the world's most prevalent disease spread by mosquitoes. Cases are increasing across the Western Pacific (e.g., Pacific Island Countries and Territories, Laos, Cambodia, Vietnam) and South East Asia (e.g., Bangladesh, Indonesia, Thailand, and Timor-Leste). All of these countries experienced significant dengue outbreaks in 2024 and 2025, and the general trend in cases globally is relentlessly upwards. 'These increases are fuelled by 1) climate change (increased temperatures encourage mosquito proliferation and shorten the time needed for viruses to replicate in their mosquito hosts), 2) increasing globalisation (and the increased movement of humans carrying the virus), 3) immunological naïveté, where human populations are being exposed to new dengue serotypes, and 4) the limited impact of existing control measures. 'According to the Pacific Syndromic Surveillance System, as of May 27th 2025, dengue cases are increasing or peaking in Fiji, Samoa, Tonga, Kiribati, and Cook Islands. There have been deaths reported from Fiji, Tonga and Samoa.' What hopes are currently on the horizon for new technologies or programmes to combat the disease? 'Current responses to dengue outbreaks largely involve the application of insecticides and the implementation of environmental 'clean-up' campaigns, but these have limited impacts. Moreover, resistance to insecticides is increasingly documented in the Pacific, and this further reduces the impact of conventional vector control. 'A safe, effective and sustainable solution exists. The Wolbachia method, developed by the non-profit World Mosquito Program, involves releasing mosquitoes infected with a bacteria that reduces their ability to transmit dengue. It has been proven to have a tremendous impact on dengue transmission around the world. Wolbachia releases have been piloted in Fiji, Vanuatu, Kiribati, and New Caledonia. Following six years of Wolbachia mosquito releases in New Caledonia, the project has been hailed a monumental success, and the French territory hasn't had a dengue epidemic since 2019. This year, releases will continue in Kiribati, and be adopted in Timor-Leste.' What is your biggest concern and/or is there anything you wish people understood better about the situation? 'The upward trend in dengue case numbers regionally will inevitably stress public health systems and impact family well-being (through both the health and economic costs of hospitalisation and the lost earnings of the sick). Sustainable ways to combat dengue, such as the Wolbachia method, are desperately needed. Vaccines are still years away from being universally affordable and applicable.' Dr Joan Ingram, Medical Advisor, Immunisation Advisory Centre, comments: What is the immediate threat posed by dengue in the Pacific region, and how is this changing? 'Dengue outbreaks are currently affecting Kiribati, Samoa, Fiji, Tonga and French Polynesia with the most cases being reported from Fiji, according to The Pacific Community (SPC). Case numbers are increasing in all of those areas, apart from in French Polynesia. There are four dengue serotypes – and both serotype 1 and serotype 2 are currently circulating. 'The Pacific Islands are vulnerable to dengue outbreaks as they have high levels of mosquitoes and dengue viruses can be introduced by infected people. 'Between 2012 and 2021, there were 69 outbreaks of dengue fever among the Pacific Islands. However, they are not unique in having dengue fever – dengue is common in many other regions including the Americas, Africa, the Middle East and Asia. 'Globally, dengue cases were at a very high level in 2024, particularly in South America. Cases increased almost 30-fold there between 2000 and 2024. Urbanisation, globalisation and climate change have contributed to this increase.' What is your biggest concern and is there anything you wish people understood better about the situation? 'Dengue is often a leading cause of fever in risk countries. Estimates are that around 6 in 1000 travellers spending a month in a risk area become unwell with dengue, with up to 30% of them being hospitalised. 'Dengue is spread by common biting mosquitoes (various Aedes species), which thrive where humans live. The main way to avoid dengue is mosquito bite avoidance. Aedes mosquitoes (unlike the malaria-transmitting Anopheles) are daytime feeders, with two peak times of biting activity in the day – 2 to 3 hours after dawn, and mid-to-late afternoon. However, they may feed all day indoors or on overcast days. 'People should regularly apply effective repellent as well as using light-coloured clothing to cover up. In addition, they should take steps to reduce mosquitoes indoors (such as screens on windows and doors), and in the environment by emptying any water-holding containers.' What hopes are currently on the horizon for new technologies or programmes to combat the disease? 'Qdenga, a dengue vaccine, is available in 30 countries overseas but not in New Zealand. It protects against dengue serotype 1 and 2 very well, especially in people who have had previous dengue. Protection against serotypes 3 and 4 is still being evaluated. 'An earlier dengue vaccine increased the risk of severe dengue in people who had not had dengue previously. It does not seem as though Qdenga does that, but it is still being monitored and most authorities prefer to administer it to people with past dengue infection although the guidelines differ. 'A new hope for the future is the use of Wolbachia-infected Aedes aegypti. Wolbachia infection blocks the transmission of the dengue virus from mosquitoes. Trials are ongoing with promising results.' No conflicts of interest. Dr Berlin Kafoa, Director, Public Health Division at The Pacific Community (SPC), comments: What is the immediate threat posed by dengue in the Pacific region, and how is this changing? ' 1. Increasing morbidity due to escalating dengue outbreaks reported across the Pacific region with circulation of multiple serotypes. 'Dengue is actively circulating in at least six Pacific Island Countries and Territories (PICTs), including Fiji (>8,000 cases, 4 deaths), Tonga (793 cases, 3 deaths), French Polynesia (>2,000 cases), Samoa (110 cases, 1 death), Cook Islands, and Kiribati. Multiple serotypes (DENV-1, DENV-2, DENV-3) are co-circulating, increasing the risk of severe dengue due to secondary infections in populations with partial immunity. ' 2. Changing epidemiology and vulnerable populations 'There is a growing incidence of severe dengue amongst children and youth with no prior dengue exposure. There are older adults coming from areas historically free of dengue. This suggests immunity gaps, but the lack of updated seroprevalence data limits precise risk profiling. ' 3. Climate and mobility as amplifiers 'Climate change and variability (e.g., rainfall, temperature) is expanding mosquito habitats and altering transmission regional and international travel and trade from endemic areas (e.g., Southeast Asia, South America) raises the risk of virus introduction.' What hopes are currently on the horizon for new technologies or programmes to combat the disease? ' 1. A need for collaboration across sectors, agencies, and countries. 'Through the Pacific Public Health Surveillance Network (PPHSN), we are working with WHO and allied members to support countries with preparedness, detection and response to dengue and other arboviral diseases. This includes: Rapid risk assessments and technical guidance Laboratory supplies and testing algorithms and Strengthening PCR testing capabilities in countries. Subtyping and WGS/Whole-Genome Sequencing via reference labs (e.g., VIDRL in Australia). Dissemination of risk communication messages through multiple channels and sharing of best practices in risk communication and community engagement ' 2. A need for predictive analytics and early warning 'We are exploring predictive algorithms that integrate climate data (e.g., rainfall, temperature), flight and mobility data, and historical outbreak and seroprevalence data. These tools aim to forecast outbreak risks and optimize vector control timing.' ' 3. Vector control capacity building to promote a One Health approach. 'The Pacific Vector Network (PVN) launched in 2023, a service arm of PPHSN, supports a coordinated response to control of vector-borne disease in the region; practical entomology training for PICTs; mosquito surveys, mapping, and surveillance; and provision of vector control equipment and insecticides.' ' 4. New tools being tested 'Other new tools being tested in the region include pilot testing of new technologies such as Sterile Insect Technique (SIT) in French Polynesia, and trials of Wolbachia introduction in Fiji, Vanuatu, New Caledonia, and Kiribati. For possible consideration, there is the introduction of dengue vaccines-contingent on availability of sero-prevalence data.' What is your biggest concern and/or is there anything you wish people understood better? 'The real risk of severe dengue is rising. Severe cases and fatalities are being reported, especially among youth. Dengue should not be dismissed as a mild illness, it can be life-threatening. 'There are gaps in immunity and surveillance. Many populations remain immunologically naive due to limited past exposure. Inadequate seroprevalence data and diagnostic capacity hinder targeted responses. 'There are changes in vector behaviours with possible increase in behaviours resistance to insecticides. 'Dengue is not the only arboviral threat which further complicates surveillance, diagnosis, and response efforts. Other threats include: Zika: Imported cases have been reported in the Pacific Rim (e.g., New Zealand from Fiji). Chikungunya: A major outbreak in La Réunion (339,000+ cases) and an imported case in Wallis and Futuna. Yellow fever: While not yet reported in the Pacific, the presence of Aedes vectors makes introduction a real risk 'There is a need to support the Pacific to acquire new technology for genomic surveillance. Genetic sequencing of dengue strains is essential to track virus movement and mutations across the region, but capacity remains limited. 'Dengue is no longer a seasonal or isolated threat in the Pacific; it is a regional health emergency shaped by climate, mobility, and historical vulnerabilities. Through a One Health multisector, multiagency and multi-country collaborative efforts with WHO, PIHOA and PPHSN partners, we are responding and building the tools and intelligence to predict, prepare and hopefully prevent the next wave.'